Kinaxo Biotechnologies Enters Agreement with Takeda
Kinaxo Biotechnologies announced that it has entered an agreement with Takeda San Diego, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Osaka, Japan. Under the agreement, Kinaxo will make its KinaTor(TM) technology available to Takeda researchers involved in drug discovery, preclinical research and clinical development. Kinaxo's Cellular Target Profiling utilizes proprietary chemical proteomics technologies combined with state-of-the-art mass spectrometry to identify and characterize a drug candidate's native molecular targets in cell lines and tissue samples.
""We consider this agreement with Takeda, the leading R&D-oriented pharmaceutical company of Japan, to be a major progress in the world-wide expansion of our business", said Dr. Andreas Jenne, tthe chief executive officer of Kinaxo. "We continue to demonstrate the validation of the KinaTor(TM) ttechnology by providing services to leading pharmaceutical and biotechnology companies, including Johnson& Johnson, Bayer-Schering, Takeda and UCB Pharma."
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!

Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Last viewed contents
Researchers find new clue to treating diabetes
Hungarian Gedeon Richter and Irish Forest Laboratories Announce Collaboration Agreement on Atypical Antipsychotic Compounds
Pall Opens New Centre of Excellence in India to Serve Fast-Growing Life Sciences Market
New discovery solves problem of anti-inflammatory substance

Elementar Analysensysteme GmbH - Langenselbold, Germany
Radioprotective Molecules - Blocking iodide transport by inhibiting the sodium iodide symporter

FluoRok - Oxford, United Kingdom
Akela and Nventa announce merger

VIBROTECH S.R.L. - Sassuolo, Italy
Caliper Life Sciences Launches Comprehensive Drug Discovery and Development Services Business
